| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Albert Stuart Reece, Gary Kenneth Huls. Impact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysis. European archives of psychiatry and clinical neuroscience. 2022-07-02. PMID:35779123. |
a longitudinal epidemiological study was conducted using national autism census data from the us department of education individuals with disabilities act (idea) 1991-2011 and nationally representative drug exposure (cigarettes, alcohol, analgesic, and cocaine abuse, and cannabis use monthly, daily, and in pregnancy) datasets from national survey of drug use and health and us census (income and ethnicity) and cdc wonder population and birth data. |
2022-07-02 |
2023-08-14 |
Not clear |
| Rose Schrott, Katherine W Greeson, Dillon King, Krista M Symosko Crow, Charles A Easley, Susan K Murph. Cannabis alters DNA methylation at maternally imprinted and autism candidate genes in spermatogenic cells. Systems biology in reproductive medicine. 2022-06-10. PMID:35687495. |
cannabis alters dna methylation at maternally imprinted and autism candidate genes in spermatogenic cells. |
2022-06-10 |
2023-08-14 |
rat |
| Estácio Amaro da Silva, Wandersonia Moreira Brito Medeiros, João Paulo Mendes Dos Santos, João Marçal Medeiros de Sousa, Filipe Barbosa da Costa, Katiúscia Moreira Pontes, Thaís Cavalcanti Borges, Carlos Espínola, Ana Hermínia Andrade E Silva, Eliane Lima Guerra Nunes, Nelson Torro, Marine Diniz da Rosa, Katy Lísias Gondim Dias de Albuquerqu. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial. Trends in psychiatry and psychotherapy. vol 44. 2022-05-26. PMID:35617670. |
evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial. |
2022-05-26 |
2023-08-13 |
Not clear |
| Michael Siani-Rose, Robert McKee, Stephany Cox, Bonni Goldstein, Donald Abrams, Myiesha Taylor, Itzhak Kure. The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder. Cannabis and cannabinoid research. 2022-03-28. PMID:35343818. |
the potential of salivary lipid-based cannabis-responsive biomarkers to evaluate medical cannabis treatment in children with autism spectrum disorder. |
2022-03-28 |
2023-08-13 |
Not clear |
| Mariana Babayeva, Haregewein Assefa, Paramita Basu, Zvi Loew. Autism and associated disorders: cannabis as a potential therapy. Frontiers in bioscience (Elite edition). vol 14. issue 1. 2022-03-23. PMID:35320905. |
autism and associated disorders: cannabis as a potential therapy. |
2022-03-23 |
2023-08-13 |
Not clear |
| Rubens Pitliuk, Christina Morotomi Funatsu Coelho, Tatyanny Paula Pinto da Costa Santos Fucc. Unexpected improvement of hyperhidrosis with cannabidiol. Einstein (Sao Paulo, Brazil). vol 20. 2022-02-16. PMID:35170710. |
the first patient received cannabidiol specific for public presentations at work, and the second patient had a diagnosis of autism spectrum disorder. |
2022-02-16 |
2023-08-13 |
Not clear |
| Víctor Ruggieri, Claudia Arbera. [Epigenetic mechanisms involved in the genesis of autism]. Medicina. vol 82 Suppl 1. 2022-02-16. PMID:35171808. |
acid, cannabis, and environmental toxins such as maternal stress, all associated with a higher prevalence of autism. |
2022-02-16 |
2023-08-13 |
Not clear |
| Serap Bilge, Barış Ekic. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature. Journal of cannabis research. vol 3. issue 1. 2021-12-16. PMID:34911567. |
cbd-enriched cannabis for autism spectrum disorder: an experience of a single center in turkey and reviews of the literature. |
2021-12-16 |
2023-08-13 |
Not clear |
| Michael Siani-Rose, Stephany Cox, Bonni Goldstein, Donald Abrams, Myiesha Taylor, Itzhak Kure. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder. Cannabis and cannabinoid research. 2021-12-07. PMID:34874191. |
cannabis-responsive biomarkers: a pharmacometabolomics-based application to evaluate the impact of medical cannabis treatment on children with autism spectrum disorder. |
2021-12-07 |
2023-08-13 |
Not clear |
| Aviv Amirav, Benny Neumark, Ksenia J Margolin Eren, Alexander B Fialkov, Noam Ta. Cannabis and its cannabinoids analysis by gas chromatography-mass spectrometry with Cold EI. Journal of mass spectrometry : JMS. vol 56. issue 6. 2021-11-15. PMID:33955098. |
finally, cannabis drugs such as ep-1 used in israel for treatment of epilepsy and for children with autism spectrum disorder (asd) were analyzed for their full cannabinoids content for learning on the entourage effect and for drug activity optimization. |
2021-11-15 |
2023-08-13 |
Not clear |
| Carolyn DiGuiseppi, Tessa Crume, Julia Van Dyke, Katherine R Sabourin, Gnakub N Soke, Lisa A Croen, Julie L Daniels, Li-Ching Lee, Laura A Schieve, Gayle C Windham, Sandra Friedman, Cordelia Robinson Rosenber. Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development. Journal of autism and developmental disorders. 2021-11-12. PMID:34767135. |
peri-pregnancy cannabis use and autism spectrum disorder in the offspring: findings from the study to explore early development. |
2021-11-12 |
2023-08-13 |
Not clear |
| Carolyn DiGuiseppi, Tessa Crume, Julia Van Dyke, Katherine R Sabourin, Gnakub N Soke, Lisa A Croen, Julie L Daniels, Li-Ching Lee, Laura A Schieve, Gayle C Windham, Sandra Friedman, Cordelia Robinson Rosenber. Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development. Journal of autism and developmental disorders. 2021-11-12. PMID:34767135. |
the association of autism spectrum disorder (asd) with self-reported maternal cannabis use from 3 months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68 months, born 2003 to 2011. |
2021-11-12 |
2023-08-13 |
Not clear |
| José Carlos Pastrana-Trejo, Fátima Duarte-Aké, Rosa Us-Camas, Clelia De-la-Peña, Linda Parker, Roger G Pertwee, Eric Murillo-Rodrígue. Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study. Central nervous system agents in medicinal chemistry. vol 21. issue 2. 2021-10-25. PMID:32972354. |
cannabidiol (cbd), a non-psychotropic constituent of cannabis sativa, has shown therapeutic promises by modulating several pathological conditions, including pain, epilepsy autism, among others. |
2021-10-25 |
2023-08-13 |
rat |
| Shani Poleg, Emad Kourieh, Angela Ruban, Guy Shapira, Noam Shomron, Boaz Barak, Daniel Offe. Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder. Translational psychiatry. vol 11. issue 1. 2021-10-21. PMID:34645786. |
behavioral aspects and neurobiological properties underlying medical cannabis treatment in shank3 mouse model of autism spectrum disorder. |
2021-10-21 |
2023-08-13 |
mouse |
| Mojdeh Mostafavi, John Gaitani. Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience. Seminars in pediatric neurology. vol 35. 2021-10-05. PMID:32892960. |
autism spectrum disorder and medical cannabis: review and clinical experience. |
2021-10-05 |
2023-08-13 |
Not clear |
| Gideon Koren, Rana Cohe. Medicinal Use of Cannabis in Children and Pregnant Women. Rambam Maimonides medical journal. vol 11. issue 1. 2021-09-30. PMID:32017681. |
however, over the last few years medicine has observed increasing numbers of children treated with cannabis for autism spectrum disorder (asd) and fetal alcohol spectrum disorder (fasd), and pregnant women treated for hyperemesis gravidarum (hg). |
2021-09-30 |
2023-08-13 |
Not clear |
| Gideon Koren, Rana Cohe. Medicinal Use of Cannabis in Children and Pregnant Women. Rambam Maimonides medical journal. vol 11. issue 1. 2021-09-30. PMID:32017681. |
specifically, cannabis may offer therapeutic advantages to behavioral symptoms of autism spectrum disorder and fetal alcohol spectrum disorder, and to the severe nausea and vomiting in hyperemesis gravidarum. |
2021-09-30 |
2023-08-13 |
Not clear |
| Samuel K Powell, Callan O'Shea, Kayla Townsley, Iya Prytkova, Kristina Dobrindt, Rahat Elahi, Marina Iskhakova, Tova Lambert, Aditi Valada, Will Liao, Seok-Man Ho, Paul A Slesinger, Laura M Huckins, Schahram Akbarian, Kristen J Brennan. Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk. Molecular psychiatry. 2021-09-26. PMID:34493831. |
specifically expressed genes in idans, as well as those from isogenic induced gabaergic and glutamatergic neurons, were enriched in loci conferring heritability for cannabis use disorder, schizophrenia, and bipolar disorder; however, each neuronal subtype demonstrated subtype-specific heritability enrichments in biologically relevant pathways, and idans alone were uniquely enriched in autism spectrum disorder risk loci. |
2021-09-26 |
2023-08-13 |
human |
| Majd Al-Soleiti, Kayla Balaj, Robyn P Thom, Christopher J McDougle, Christopher J Kear. Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder. Journal of autism and developmental disorders. 2021-09-10. PMID:34505186. |
there is increasing interest in investigating cannabis for behavioral symptoms in individuals with autism spectrum disorder (asd). |
2021-09-10 |
2023-08-13 |
human |
| Sarah Fletcher, Colleen Pawliuk, Angie Ip, Linda Huh, S Rod Rassekh, Tim F Oberlander, Harold Side. Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review. Child: care, health and development. 2021-08-31. PMID:34403168. |
medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review. |
2021-08-31 |
2023-08-13 |
Not clear |